Eduardo Vilar‐Gómez

6.9k total citations · 5 hit papers
76 papers, 4.3k citations indexed

About

Eduardo Vilar‐Gómez is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eduardo Vilar‐Gómez has authored 76 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 48 papers in Hepatology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eduardo Vilar‐Gómez's work include Liver Disease Diagnosis and Treatment (67 papers), Liver Disease and Transplantation (37 papers) and Liver Diseases and Immunity (16 papers). Eduardo Vilar‐Gómez is often cited by papers focused on Liver Disease Diagnosis and Treatment (67 papers), Liver Disease and Transplantation (37 papers) and Liver Diseases and Immunity (16 papers). Eduardo Vilar‐Gómez collaborates with scholars based in United States, Cuba and Spain. Eduardo Vilar‐Gómez's co-authors include Naga Chalasani, Luis Calzadilla Bertot, Manuel Romero‐Gómez, Licet Gonzalez‐Fabian, M. Diago, Bienvenido Gra‐Oramas, Scott L. Friedman, Raj Vuppalanchi, Samer Gawrieh and Leon A. Adams and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Eduardo Vilar‐Gómez

71 papers receiving 4.3k citations

Hit Papers

Weight Loss Through Lifestyle Modification Significantly ... 2015 2026 2018 2022 2015 2018 2017 2021 2024 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
    2015 1.7k citations Eduardo Vilar‐Gómez, Luis Calzadilla Bertot et al. Gastroenterology profile →
  2. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
    2018 574 citations Eduardo Vilar‐Gómez, Luis Calzadilla Bertot et al. Gastroenterology profile →
  3. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
    2017 436 citations Eduardo Vilar‐Gómez, Naga Chalasani Journal of Hepatology profile →
  4. High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population
    2021 180 citations Eduardo Vilar‐Gómez, Lauren Nephew et al. Hepatology profile →
  5. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
    2024 65 citations Eduardo Vilar‐Gómez et al. Journal of Hepatology profile →

Peers

Eduardo Vilar‐Gómez
Alina M. Allen United States
Youssef Younossi United States
Dawn M. Torres United States
Luis Calzadilla Bertot Australia
Fabio Nascimbeni Italy
Manirath Srishord United States
Aynur Ünalp United States
Stefano Ballestri Italy
James M. Paik United States
George Cholankeril United States
Alina M. Allen United States
Eduardo Vilar‐Gómez
Citations per year, relative to Eduardo Vilar‐Gómez Eduardo Vilar‐Gómez (= 1×) peers Alina M. Allen

Countries citing papers authored by Eduardo Vilar‐Gómez

Since Specialization
Citations

This map shows the geographic impact of Eduardo Vilar‐Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Vilar‐Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Vilar‐Gómez more than expected).

Fields of papers citing papers by Eduardo Vilar‐Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Vilar‐Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Vilar‐Gómez. The network helps show where Eduardo Vilar‐Gómez may publish in the future.

Co-authorship network of co-authors of Eduardo Vilar‐Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Vilar‐Gómez. A scholar is included among the top collaborators of Eduardo Vilar‐Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Vilar‐Gómez. Eduardo Vilar‐Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vilar‐Gómez, Eduardo, Katherine P. Yates, David E. Kleiner, et al.. (2025). Genetic and non-genetic drivers of histological progression and regression in MASLD. Journal of Hepatology. 84(3). 502–516. 1 indexed citations
2.
Kaya, Eda, Eduardo Vilar‐Gómez, Raj Vuppalanchi, & Yusuf Yılmaz. (2025). Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease. Annals of Hepatology. 30(1). 101907–101907.
3.
Gromski, Mark A., Fatih Akisik, Eduardo Vilar‐Gómez, et al.. (2024). Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive Diseases and Sciences. 69(4). 1421–1429. 2 indexed citations
4.
Sterling, Richard K., Eduardo Vilar‐Gómez, Laura Wilson, et al.. (2024). Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American Journal of Gastroenterology. 119(8). 1483–1495. 2 indexed citations
5.
Chalasani, Naga, Eduardo Vilar‐Gómez, Rohit Loomba, et al.. (2024). PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology. 80(5). 1212–1226. 18 indexed citations
6.
Samala, Niharika, et al.. (2024). Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease. Digestive Diseases and Sciences. 69(4). 1444–1453. 4 indexed citations
7.
Orman, Eric S., Archita P. Desai, Marwan Ghabril, et al.. (2023). Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. The American Journal of Gastroenterology. 119(2). 287–296. 2 indexed citations
8.
Nephew, Lauren, Eduardo Vilar‐Gómez, Carla Kettler, et al.. (2023). Clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis. Liver International. 44(1). 241–249. 1 indexed citations
9.
Patidar, Kavish R., Mohammad Adibuzzaman, James E. Slaven, et al.. (2021). Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver International. 42(1). 187–198. 4 indexed citations
10.
Vilar‐Gómez, Eduardo, Mark A. Gromski, Fatih Akisik, et al.. (2021). Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status. Liver International. 41(11). 2703–2711. 9 indexed citations
11.
Vilar‐Gómez, Eduardo, Silvia Sookoian, Carlos J. Pirola, et al.. (2020). ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. Gastroenterology. 159(3). 929–943. 21 indexed citations
12.
Vilar‐Gómez, Eduardo, et al.. (2020). Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System. Clinical Gastroenterology and Hepatology. 18(10). 2305–2314.e12. 54 indexed citations
13.
14.
Vilar‐Gómez, Eduardo & Naga Chalasani. (2019). Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. Publisher. 1 indexed citations
15.
Vilar‐Gómez, Eduardo & Naga Chalasani. (2017). Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Journal of Hepatology. 68(2). 305–315. 436 indexed citations breakdown →
16.
Vilar‐Gómez, Eduardo, et al.. (2012). The natural history of compensated HCV-related cirrhosis: A prospective long-term study. Journal of Hepatology. 58(3). 434–444. 56 indexed citations
17.
Bertot, Luis Calzadilla, et al.. (2011). Modelos pronósticos para la cirrosis hepática. SHILAP Revista de lepidopterología.
18.
19.
Vilar‐Gómez, Eduardo. (2010). Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C. World Journal of Gastroenterology. 16(21). 2638–2638. 30 indexed citations
20.
Vilar‐Gómez, Eduardo, et al.. (2003). Influencia de factores epidemiológicos en la progresión de la fibrosis en la hepatitis crónica C. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alina M. Allen Breakdown of academic impact, for papers by Youssef Younossi Breakdown of academic impact, for papers by Dawn M. Torres Breakdown of academic impact, for papers by Luis Calzadilla Bertot Breakdown of academic impact, for papers by Fabio Nascimbeni Breakdown of academic impact, for papers by Manirath Srishord Breakdown of academic impact, for papers by Aynur Ünalp Breakdown of academic impact, for papers by Stefano Ballestri Breakdown of academic impact, for papers by James M. Paik Breakdown of academic impact, for papers by George Cholankeril
Rankless by CCL
2026